PFIZER INC.
πΊπΈUnited States
- Country
- πΊπΈUnited States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
A Phase 1 Study Of PF-00868554 In Hepatitis C Virus (HCV) Positive Patients
- First Posted Date
- 2007-03-08
- Last Posted Date
- 2014-02-17
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 32
- Registration Number
- NCT00445315
- Locations
- π¬π§
Pfizer Investigational Site, Dundee, United Kingdom
Evaluation of A Novel Methodology in the Assessment of Urethral Function Using [S,S]-Reboxetine in Healthy Volunteers
Not Applicable
Completed
- Conditions
- Healthy
- First Posted Date
- 2007-03-08
- Last Posted Date
- 2011-06-01
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 12
- Registration Number
- NCT00444548
- Locations
- π©π°
Pfizer Investigational Site, Hellerup, Denmark
Post Marketing Surveillance Study To Observe Safety And Efficacy Of Sutene
- First Posted Date
- 2007-03-08
- Last Posted Date
- 2017-02-01
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 520
- Registration Number
- NCT00444795
- Locations
- π°π·
Hwasun Hospital, Chonnam National University, Cheonnam, Korea, Republic of
π°π·Soonchunhyang University Bucheon Hospital, Bucheon, Gyeonggi-do, Korea, Republic of
π°π·Chosun University Hospital, Gwang Joo, Korea, Republic of
Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine for Overactive Bladder (OAB)
Phase 3
Completed
- Conditions
- Overactive Bladder
- Interventions
- First Posted Date
- 2007-03-08
- Last Posted Date
- 2015-03-24
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 1712
- Registration Number
- NCT00444925
- Locations
- πΊπ¦
Pfizer Investigational Site, Zaporizhzhia, Ukraine
A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol.
- First Posted Date
- 2007-03-06
- Last Posted Date
- 2013-05-24
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 123
- Registration Number
- NCT00443534
- Locations
- π¬π§
Pfizer Investigational Site, Manchester, United Kingdom
Long Term Study Of Amlodipine 10mg With Hypertension For Whom Amlodipine 5mg Is Insufficient
- First Posted Date
- 2007-03-06
- Last Posted Date
- 2009-10-28
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 134
- Registration Number
- NCT00443456
- Locations
- π―π΅
Pfizer Investigational Site, Fukuoka, Japan
Vaginal Heat Wash-out (HWO) in 4 Groups of Women (Pre- and Postmenopausal With and Without Female Sexual Arousal Disorder (FSAD)).
Phase 1
Completed
- Conditions
- Sexual Dysfunction, Physiological
- Interventions
- Device: Vaginal Heat Wash-Out Device
- First Posted Date
- 2007-03-05
- Last Posted Date
- 2019-05-28
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 64
- Registration Number
- NCT00443248
- Locations
- π¦πΊ
Pfizer Investigational Site, Nedlands, Western Australia, Australia
Effect Of Menstrual Cycle On Vaginal Blood Flow In Pre-Menopausal Healthy Women.
Phase 1
Completed
- Conditions
- Sexual Dysfunction, Physiological
- Interventions
- Device: Vaginal Heat Wash-Out Device
- First Posted Date
- 2007-03-05
- Last Posted Date
- 2019-05-28
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 12
- Registration Number
- NCT00443027
- Locations
- π¦πΊ
Pfizer Investigational Site, Nedlands, Western Australia, Australia
A Clinical Trial Comparing The Efficacy And Safety Of 2 Different Initial Dose Prescriptions For Exubera.
Phase 4
Terminated
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- Drug: Inhaled Human Insulin (Exubera)
- First Posted Date
- 2007-02-21
- Last Posted Date
- 2009-05-11
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 49
- Registration Number
- NCT00437489
- Locations
- πΈπ¬
Pfizer Investigational Site, Singapore, Singapore
PF-00477736 Is Being Studied In Advanced Solid Tumors In Combination With Chemotherapy With Gemcitabine
- First Posted Date
- 2007-02-19
- Last Posted Date
- 2012-04-03
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 43
- Registration Number
- NCT00437203
- Locations
- π¦πΊ
Pfizer Investigational Site, East Melbourne, Victoria, Australia
Β© Copyright 2025. All Rights Reserved by MedPath